BamSEC and AlphaSense Join Forces
Learn More

9 Meters Biopharma Inc

Formerly OTC: NMTRQ
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 7 pages Second Forbearance and Amendment Agreement
12/34/56
EX-10.1
from 8-K 5 pages Separation Agreement and Release
12/34/56
EX-10.1
from 8-K 8 pages Amendment No. 1 to Forbearance Agreement
12/34/56
EX-10.1
from 8-K 10 pages Forbearance Agreement
12/34/56
EX-10.30
from 10-K 3 pages Via Email [Full Name]
12/34/56
EX-10.1
from 8-K 32 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 6 pages First Amendment to Amended and Restated Senior Secured Convertible Note Due 2025
12/34/56
EX-10.1
from 10-Q 68 pages 9 Meters Biopharma, Inc. Amended and Restated Senior Secured Convertible Note Due 2025
12/34/56
EX-10.1
from 8-K 45 pages Lease Agreement Between Crabtree Terrace Holdings LLC ("Landlord") and 9 Meters Biopharma, Inc
12/34/56
EX-10.1
from 10-Q 52 pages Exclusive License Agreement
12/34/56
EX-10.2
from 8-K 74 pages 9 Meters Biopharma, Inc. Senior Secured Convertible Note Due 2025
12/34/56
EX-10.1
from 8-K 73 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 9 pages 9 Meters Biopharma, Inc. 2022 Stock Incentive Plan Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 15 pages 9 Meters Biopharma, Inc. 2022 Stock Incentive Plan 2022 Stock Incentive Plan Approved by the Board and Stockholders on May 4, 2022 and June 22, 2022, Respectively
12/34/56
EX-10.17.1
from 10-K 4 pages First Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 8 pages Separation and Consulting Agreement
12/34/56
EX-10.1
from 8-K 5 pages On Behalf of 9 Meters Biopharma, Inc. (The “Company”), I Am Very Pleased to Extend an Offer of Employment to You. We Hope That You Will Accept This Offer and Look Forward to Having a Mutually Successful Relationship With You. the Purpose of This Letter Is to Summarize the Terms of Your Employment With the Company Should You Accept This Offer
12/34/56
EX-10.1
from 8-K 1 page Amendment to the 9 Meters Biopharma, Inc. 2012 Omnibus Incentive Plan, as Amended
12/34/56
EX-10.11
from 10-Q 6 pages Rdd Pharma Ltd
12/34/56
EX-10.10
from 10-Q 40 pages Amended and Restated License Agreement
12/34/56